Cariboubio.com
Visit cariboubio.com-
573.3K
Global Rank
-
534
Daily Visitors
-
4 days ago
Last scanned
-
12 years
Domain Age
Cariboubio.com
Visit cariboubio.com
About Website
Updated:
Caribou Biosciences | Developing Sophisticated Allogeneic Cell Therapies
Caribou is a clinical-stage biopharmaceutical company focused on developing genome-edited allogeneic cell therapies for devastating human diseases.
Network Data
This website is hosted with Hubbard Radio, LLC, which reserves the following IP addresses for cariboubio.com: 64.19.220.132. Moreover, DNS used with this website include ns-1524.awsdns-62.org, ns-2019.awsdns-60.co.uk, ns-245.awsdns-30.com, ns-835.awsdns-40.net. Subnet identifier ranges from 64.19.220.0 to 64.19.220.255. Classless Inter-Domain Routing (CIDR) is 64.19.220.0/24. ARIN net type is Reassigned.
-
573.3K
Global Rank
-
534
Daily Visitors
-
4 days ago
Last scanned
-
12 years
Domain Age
Network
ADDRESSING DETAILS
-
Hosting Company
-
IPs
-
DNS
ns-1524.awsdns-62.org
ns-2019.awsdns-60.co.uk
ns-245.awsdns-30.com
ns-835.awsdns-40.net
Whois
OWNERSHIP
-
Created
2011-12-07
-
Expires
2024-12-07
-
Owner
On behalf of cariboubio.com owner (Identity Protection Service)
-
Registar
AMAZON REGISTRAR, INC.
-
Owner Emails
Domain & Keywords
The registrar of cariboubio.com is AMAZON REGISTRAR, INC. and the name expires on 2024-12-07. According to open source data, you can reach the owner at e93fedeb-e927-4fb4-9992-04de348e16fc@identity-protect.org but please make sure you have a good reason for unsolicited messages. Their country of residence is United Kingdom.
- caribou
- caribou biosciences
- caribou biosciences stock
- rachel haurwitz
- caribou biosciences ipo
Websites similar to cariboubio.com
-
mpnforum.com-
Global rank
N/A
-
Daily Visitors
534
-
-
bseindia.com-
Global rank
12.9K
-
Daily Visitors
167.8K
-
-
nseindia.com-
Global rank
13.8K
-
Daily Visitors
458.8K
-
-
bursamalaysia.com-
Global rank
52K
-
Daily Visitors
27.8K
-
-
hispanicprwire.com-
Global rank
431.2K
-
Daily Visitors
1K
-